相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Neuromyelitis optica spectrum disorders with unevenly clustered attack occurrence
Tetsuya Akaishi et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)
Silent progression in disease activity-free relapsing multiple sclerosis
Bruce A. C. Cree et al.
ANNALS OF NEUROLOGY (2019)
Neuromyelitis optica spectrum disorders: still evolving and broadening
Kazuo Fujihara
CURRENT OPINION IN NEUROLOGY (2019)
Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis
Hans Lassmann
FRONTIERS IN IMMUNOLOGY (2019)
Clinical Application of 2017 McDonald Diagnostic Criteria for Multiple Sclerosis
Vittorio Mantero et al.
JOURNAL OF CLINICAL NEUROLOGY (2018)
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Alan J. Thompson et al.
LANCET NEUROLOGY (2018)
Diagnosis and Treatment of NMO Spectrum Disorder and MOG-Encephalomyelitis
Nadja Borisow et al.
FRONTIERS IN NEUROLOGY (2018)
Brain MRI atrophy quantification in MS From methods to clinical application
Maria A. Rocca et al.
NEUROLOGY (2017)
Subclinical retinal atrophy in the unaffected fellow eyes of multiple sclerosis and neuromyelitis optica
Tetsuya Akaishi et al.
JOURNAL OF NEUROIMMUNOLOGY (2017)
Whole brain and grey matter volume of Japanese patients with multiple sclerosis
Tetsuya Akaishi et al.
JOURNAL OF NEUROIMMUNOLOGY (2017)
Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later
Sean J. Pittock et al.
SPECIAL ISSUE: THE YEAR IN NEUROLOGY AND PSYCHIATRY (2016)
Longitudinal patterns of leukoaraiosis and brain atrophy in symptomatic small vessel disease
Christian Lambert et al.
BRAIN (2016)
Progressive multiple sclerosis
Daniel Ontaneda et al.
CURRENT OPINION IN NEUROLOGY (2015)
Challenges and opportunities in designing clinical trials for neuromyelitis optica
Brian G. Weinshenker et al.
NEUROLOGY (2015)
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders
Dean M. Wingerchuk et al.
NEUROLOGY (2015)
MRI characteristics of neuromyelitis optica spectrum disorder An international update
Ho Jin Kim et al.
NEUROLOGY (2015)
MOG cell-based assay detects non-MS patients with inflammatory neurologic disease
Patrick Waters et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2015)
Defining the clinical course of multiple sclerosis The 2013 revisions
Fred D. Lublin et al.
NEUROLOGY (2014)
Aquaporin 4 IgG Serostatus and Outcome in Recurrent Longitudinally Extensive Transverse Myelitis
Yujuan Jiao et al.
JAMA NEUROLOGY (2014)
Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica
Yujuan Jiao et al.
NEUROLOGY (2013)
Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria
Chris H. Polman et al.
ANNALS OF NEUROLOGY (2011)
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
Jeffrey A. Cohen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Impact of white matter hyperintensity volume progression on rate of cognitive and motor decline
L. C. Silbert et al.
NEUROLOGY (2008)
The patient knows best: significant change in the physical component of the Multiple Sclerosis Impact Scale (MSIS-29 physical)
Lisa Costelloe et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2007)
Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre
Toshiyuki Takahashi et al.
BRAIN (2007)
Establishment of a New Sensitive Assay for Anti-Human Aquaporin-4 Antibody in Neuromyelitis Optica
Toshiyuki Takahashi et al.
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE (2006)
分享论文
